- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07615244
MICROVASCULAR DAMAGE IN THROMBOTIC THROMBOCYTOPENIC PURPURA (MITHO)
STUDY OF MICROVASCULAR DAMAGE IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA
The goal of this interventional, non-pharmacological clinical study is to assess microcirculatory dysfunction in patients with thrombotic thrombocytopenic purpura (TTP), both during the acute phase and in remission, compared with the general population.
Microcirculatory damage will be defined as the presence of at least one abnormal instrumental finding among brain magnetic resonance imaging (MRI), optical coherence tomography angiography (OCT-A), and nailfold videocapillaroscopy.
This is a monocentric, national study including two patient cohorts:
Cohort 1: patients enrolled during the acute phase Cohort 2: patients enrolled during remission Participants will be followed for three years with a total of five study visits.
Researchers will not test any drug but will perform detailed clinical, laboratory, and instrumental assessments to evaluate microvascular involvement over time.
Participants will:
- Undergo clinical evaluation, including internal medicine and neurological assessments
- Provide blood and urine samples for laboratory analyses
- Undergo instrumental examinations such as brain MRI, OCT-A, and nailfold videocapillaroscopy
- Receive psychological/neuropsychological evaluations
- Attend follow-up visits over a 3-year period (at baseline, 3 months [cohort 1 only], 12, 24, and 36 months)
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
- Diagnosetest: Factor VIII (FVIII)
- Diagnosetest: Von Willebrand factor (VWF) antigen
- Diagnosetest: VWF:RCo
- Diagnosetest: VWF-propeptide
- Diagnosetest: VWF multimers
- Diagnosetest: sP-selectin
- Diagnosetest: sCD40L
- Diagnosetest: F1+2
- Diagnosetest: VEGF-A
- Diagnosetest: VCAM
- Diagnosetest: ICAM
- Diagnosetest: IL-1β
- Diagnosetest: IL-6
- Diagnosetest: PTX3
- Diagnosetest: BlyS
- Diagnosetest: Neutrophil elastase and myeloperoxidase (NETs) markers
- Diagnosetest: soluble C5b-9
- Diagnosetest: C5a
- Diagnosetest: NFL
- Diagnosetest: GFAP
- Genetisch: Whole exome sequencing - WES
- Diagnosetest: Proteomic Analysis
- Diagnosetest: evaluation of thrombus formation with Total Thrombus formation Analysis System (T-TAS)
- Diagnosetest: Microfluidic Flow Chamber
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Milano
-
Milan, Milano, Italien, 20122
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
- aged ≥18 years
- diagnosis of TTP (either congenital or acquired immune-mediated TTP)
- referred at our hospital (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, S.C. Medicina - Emostasi e Trombosi)
- providing a signed informed consent
Exclusion Criteria:
- Patients who do not possess the above inclusion criteria
- Patients who have known contraindications to the instrumental exam included in the study.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Diagnose
- Zuteilung: Nicht randomisiert
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Sonstiges: Acute TTP
Patients enrolled during acute phase (cohort 1), T0= within 15 days from hospital admission.
|
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
|
|
Sonstiges: Remission TTP
Patients enrolled during clinical remission (cohort 2), T0= check-up visit performed at more than 3 months from clinical response of the previous episode
|
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
Diagnosetest: evaluation of thrombus formation with Total Thrombus formation Analysis System (T-TAS)
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Prevalence
Zeitfenster: From enrollment to the last visit (after 36 months from Time 0)
|
Prevalence of microcirculation damage in iTTP patients compared to general population
|
From enrollment to the last visit (after 36 months from Time 0)
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Cerebral microcirculation lesions
Zeitfenster: From enrollment to the last visit (after 36 months from Time 0)
|
Evaluate cerebral microcirculation lesions (via brain MRI) in both acute and remission phases of TTP to monitor organ damage progression over time
|
From enrollment to the last visit (after 36 months from Time 0)
|
|
Retinal microcirculation changes
Zeitfenster: From enrollment to the last visit (after 36 months from Time 0)
|
Assess retinal microcirculation changes (using OCT and OCT-A) during acute and remission phases of TTP to track organ damage evolution
|
From enrollment to the last visit (after 36 months from Time 0)
|
|
Peripheral microcirculation
Zeitfenster: From enrollment to the last visit (after 36 months from Time 0)
|
Analyze peripheral microcirculation (with nailfold videocapillaroscopy) in acute and remission phases to evaluate progression of organ involvement in TTP
|
From enrollment to the last visit (after 36 months from Time 0)
|
|
Association between cerebral MRI lesions and cognitive or psychological symptoms
Zeitfenster: From enrollment to the last visit (36 months from Time 0)
|
Explore the relationship between cerebral MRI lesions and cognitive or psychological symptoms during TTP remission, assessing symptom progression
|
From enrollment to the last visit (36 months from Time 0)
|
|
Modification of preclinical biomarkers
Zeitfenster: From enrollment to the last visit (36 months from Time 0)
|
Explore the modification of preclinical biomarkers over time at different stage of the disease
|
From enrollment to the last visit (36 months from Time 0)
|
|
Associations between preclinical biomarkers and microcirculatory damage
Zeitfenster: From enrollment to the last visit (36 months from Time 0)
|
Identify associations between preclinical biomarkers and microcirculatory damage in both acute and remission phases of TTP to predict risk and progression
|
From enrollment to the last visit (36 months from Time 0)
|
Mitarbeiter und Ermittler
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
- Zytopenie
- Pathologische Prozesse
- Blutung
- Hautmanifestationen
- Hämatologische Erkrankungen
- Blutgerinnungsstörungen
- Erkrankungen der Blutplättchen
- Thrombotische Mikroangiopathien
- Purpura, Thrombozytopenie
- Purpura
- Thrombozytopenie
- Thrombophilie
- Pathologische Zustände, Anzeichen und Symptome
- Anzeichen und Symptome
- Hämische und lymphatische Krankheiten
- Purpura, thrombotisch thrombozytopenisch
- Untersuchungstechniken
- Genetische Techniken
- Sequenzanalyse
- Sequenzanalyse, DNA
- Ganzes Genomsequenzierung
- Exome -Sequenzierung
Andere Studien-ID-Nummern
- IRCCSMaggioreH (IRCCSMaggioreH)
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur TTP – Thrombotisch-thrombozytopenische Purpura
-
TakedaNoch keine Rekrutierung
-
Turkish Hematology AssociationSanofiRekrutierungTTP – Thrombotisch-thrombozytopenische PurpuraTruthahn
-
TakedaFür die Vermarktung zugelassenThrombotisch-thrombozytopenische Purpura (TTP)
-
BloodworksUniversity of WashingtonAbgeschlossenPurpura, thrombotisch thrombozytopenisch | TTPVereinigte Staaten
-
TakedaRekrutierungThrombotisch-thrombozytopenische Purpura (TTP)Deutschland, Österreich
-
Fondazione Luigi VillaRekrutierung
-
Baxalta now part of ShireAbgeschlossenHereditäre thrombotisch-thrombozytopenische Purpura (TTP)Vereinigte Staaten, Deutschland, Vereinigtes Königreich, Schweiz, Österreich, Japan, Polen
-
OctapharmaBeendetThrombotisch-thrombozytopenische Purpura (TTP)Vereinigte Staaten
-
The First Affiliated Hospital of Soochow UniversityRekrutierung
-
University College, LondonRekrutierungTTP – Thrombotisch-thrombozytopenische PurpuraVereinigtes Königreich
Klinische Studien zur Factor VIII (FVIII)
-
BayerAbgeschlossenHämophilie AVereinigte Staaten
-
Hospices Civils de LyonBeendetHämophilie AFrankreich
-
Baxalta now part of ShireAbgeschlossen
-
Hoffmann-La RocheChugai PharmaceuticalAbgeschlossenHämophilie AAustralien, Taiwan, Korea, Republik von, Frankreich, Deutschland, Italien, Südafrika, Spanien, Vereinigte Staaten, Japan, Irland, Polen, Vereinigtes Königreich, Costa Rica
-
Dhaka Medical CollegeNoch keine Rekrutierung
-
Federico II UniversityAbgeschlossen
-
Fondazione Angelo Bianchi BonomiSintesi Research SrlAbgeschlossenHämophilie AVereinigte Staaten, Indien, Spanien, Argentinien, Österreich, Brasilien, Chile, Ägypten, Iran, Islamische Republik, Italien, Mexiko, Saudi-Arabien, Südafrika, Truthahn
-
Chulalongkorn UniversityAbgeschlossen
-
Hoffmann-La RocheChugai PharmaceuticalRekrutierung